nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—ALDH2—Ethanol oxidation—ALDH1A1—kidney cancer	0.0228	0.0872	CbGpPWpGaD
Nitroglycerin—ALDH2—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.016	0.0612	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Nitric oxide stimulates guanylate cyclase—KCNMA1—kidney cancer	0.0157	0.0598	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Nitric oxide stimulates guanylate cyclase—KCNMA1—kidney cancer	0.0157	0.0598	CbGpPWpGaD
Nitroglycerin—ALDH2—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.0157	0.0598	CbGpPWpGaD
Nitroglycerin—ALDH2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.014	0.0533	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Nitric oxide stimulates guanylate cyclase—KCNMA1—kidney cancer	0.014	0.0533	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—CNN2—kidney cancer	0.0126	0.048	CbGpPWpGaD
Nitroglycerin—GUCY1A3—nephron tubule—kidney cancer	0.00974	0.0607	CbGeAlD
Nitroglycerin—NPR1—nephron tubule—kidney cancer	0.00904	0.0564	CbGeAlD
Nitroglycerin—GUCY1A3—renal system—kidney cancer	0.00885	0.0552	CbGeAlD
Nitroglycerin—GUCY1B3—renal system—kidney cancer	0.00879	0.0548	CbGeAlD
Nitroglycerin—GUCY1A3—kidney—kidney cancer	0.00856	0.0534	CbGeAlD
Nitroglycerin—GUCY1B3—kidney—kidney cancer	0.0085	0.053	CbGeAlD
Nitroglycerin—GUCY1A3—cortex of kidney—kidney cancer	0.00834	0.052	CbGeAlD
Nitroglycerin—GUCY1B3—cortex of kidney—kidney cancer	0.00828	0.0516	CbGeAlD
Nitroglycerin—NPR1—renal system—kidney cancer	0.00822	0.0512	CbGeAlD
Nitroglycerin—ALDH2—nephron tubule—kidney cancer	0.00821	0.0512	CbGeAlD
Nitroglycerin—NPR1—kidney—kidney cancer	0.00795	0.0495	CbGeAlD
Nitroglycerin—GUCY1A3—cardiac atrium—kidney cancer	0.00793	0.0494	CbGeAlD
Nitroglycerin—GUCY1B3—cardiac atrium—kidney cancer	0.00787	0.0491	CbGeAlD
Nitroglycerin—NPR1—cortex of kidney—kidney cancer	0.00774	0.0482	CbGeAlD
Nitroglycerin—ALDH2—renal system—kidney cancer	0.00746	0.0465	CbGeAlD
Nitroglycerin—NPR1—cardiac atrium—kidney cancer	0.00736	0.0459	CbGeAlD
Nitroglycerin—ALDH2—kidney—kidney cancer	0.00721	0.045	CbGeAlD
Nitroglycerin—ALDH2—cortex of kidney—kidney cancer	0.00703	0.0438	CbGeAlD
Nitroglycerin—ALDH2—Tryptophan metabolism—ALDH1A1—kidney cancer	0.00673	0.0257	CbGpPWpGaD
Nitroglycerin—ALDH2—gonad—kidney cancer	0.00669	0.0417	CbGeAlD
Nitroglycerin—ALDH2—cardiac atrium—kidney cancer	0.00668	0.0417	CbGeAlD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—RYR1—kidney cancer	0.0066	0.0252	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Platelet homeostasis—KCNMA1—kidney cancer	0.0061	0.0233	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—KCNMA1—kidney cancer	0.0061	0.0233	CbGpPWpGaD
Nitroglycerin—ALDH2—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.00556	0.0212	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Platelet homeostasis—KCNMA1—kidney cancer	0.00544	0.0208	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Platelet homeostasis—ITPR2—kidney cancer	0.00495	0.0189	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Platelet homeostasis—ITPR2—kidney cancer	0.00495	0.0189	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00441	0.0169	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Platelet homeostasis—ITPR2—kidney cancer	0.00441	0.0169	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—ACY1—kidney cancer	0.00428	0.0163	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—CALD1—kidney cancer	0.00395	0.0151	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ITPR2—kidney cancer	0.00255	0.00973	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00243	0.00928	CbGpPWpGaD
Nitroglycerin—ALDH2—Tryptophan metabolism—CYP1A1—kidney cancer	0.00239	0.00912	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—ALDH1A1—kidney cancer	0.00234	0.00895	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—L1CAM—kidney cancer	0.00218	0.00832	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—L1CAM—kidney cancer	0.00218	0.00832	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—L1CAM—kidney cancer	0.00194	0.00741	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ANXA2—kidney cancer	0.00165	0.0063	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ANXA2—kidney cancer	0.00165	0.0063	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00157	0.00598	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ANXA2—kidney cancer	0.00147	0.00562	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTT1—kidney cancer	0.00138	0.00526	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—KCNMA1—kidney cancer	0.00137	0.00522	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—KCNMA1—kidney cancer	0.00137	0.00522	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—PTGS1—kidney cancer	0.00129	0.00493	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—KCNMA1—kidney cancer	0.00126	0.00483	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.00122	0.00466	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—KCNMA1—kidney cancer	0.00122	0.00465	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—GRB7—kidney cancer	0.00119	0.00456	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—GRB7—kidney cancer	0.00119	0.00456	CbGpPWpGaD
Nitroglycerin—ALDH2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00117	0.00446	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—ITPR2—kidney cancer	0.00111	0.00424	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—ITPR2—kidney cancer	0.00111	0.00424	CbGpPWpGaD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00106	0.00406	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—GRB7—kidney cancer	0.00106	0.00406	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—ITPR2—kidney cancer	0.000989	0.00378	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTP1—kidney cancer	0.000955	0.00365	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—ACHE—kidney cancer	0.000935	0.00357	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—GSTM1—kidney cancer	0.000877	0.00335	CbGpPWpGaD
Nitroglycerin—ALDH2—Biological oxidations—CYP1A1—kidney cancer	0.000832	0.00318	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—BCHE—kidney cancer	0.000815	0.00311	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IFNA1—kidney cancer	0.000814	0.00311	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IFNA1—kidney cancer	0.000814	0.00311	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—IFNA2—kidney cancer	0.000758	0.00289	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IFNA2—kidney cancer	0.000758	0.00289	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Myometrial Relaxation and Contraction Pathways—JUN—kidney cancer	0.000752	0.00287	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ACY1—kidney cancer	0.000732	0.00279	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—IFNA1—kidney cancer	0.000726	0.00277	CbGpPWpGaD
Nitroglycerin—Nausea—Pazopanib—kidney cancer	0.000718	0.00124	CcSEcCtD
Nitroglycerin—Paraesthesia—Sunitinib—kidney cancer	0.000716	0.00124	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000715	0.00124	CcSEcCtD
Nitroglycerin—Dyspnoea—Sunitinib—kidney cancer	0.00071	0.00123	CcSEcCtD
Nitroglycerin—Hypersensitivity—Vinblastine—kidney cancer	0.000706	0.00122	CcSEcCtD
Nitroglycerin—Hypersensitivity—Everolimus—kidney cancer	0.000703	0.00122	CcSEcCtD
Nitroglycerin—Flushing—Paclitaxel—kidney cancer	0.000699	0.00121	CcSEcCtD
Nitroglycerin—Cardiac disorder—Paclitaxel—kidney cancer	0.000699	0.00121	CcSEcCtD
Nitroglycerin—Infestation—Capecitabine—kidney cancer	0.000689	0.00119	CcSEcCtD
Nitroglycerin—Infestation NOS—Capecitabine—kidney cancer	0.000689	0.00119	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000688	0.00119	CcSEcCtD
Nitroglycerin—Asthenia—Vinblastine—kidney cancer	0.000687	0.00119	CcSEcCtD
Nitroglycerin—Asthenia—Everolimus—kidney cancer	0.000685	0.00118	CcSEcCtD
Nitroglycerin—Angiopathy—Paclitaxel—kidney cancer	0.000684	0.00118	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—IGF2—kidney cancer	0.000682	0.00261	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IGF2—kidney cancer	0.000682	0.00261	CbGpPWpGaD
Nitroglycerin—Immune system disorder—Paclitaxel—kidney cancer	0.000681	0.00118	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Paclitaxel—kidney cancer	0.000679	0.00118	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000677	0.00117	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IFNA2—kidney cancer	0.000675	0.00258	CbGpPWpGaD
Nitroglycerin—Pruritus—Everolimus—kidney cancer	0.000675	0.00117	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Vincristine—kidney cancer	0.000674	0.00117	CcSEcCtD
Nitroglycerin—Arrhythmia—Paclitaxel—kidney cancer	0.000673	0.00117	CcSEcCtD
Nitroglycerin—Stomatitis—Capecitabine—kidney cancer	0.000671	0.00116	CcSEcCtD
Nitroglycerin—Infection—Vincristine—kidney cancer	0.00067	0.00116	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000662	0.00115	CcSEcCtD
Nitroglycerin—Nervous system disorder—Vincristine—kidney cancer	0.000661	0.00114	CcSEcCtD
Nitroglycerin—Asthenia—Erlotinib—kidney cancer	0.00066	0.00114	CcSEcCtD
Nitroglycerin—Mental disorder—Paclitaxel—kidney cancer	0.00066	0.00114	CcSEcCtD
Nitroglycerin—Urticaria—Sorafenib—kidney cancer	0.000658	0.00114	CcSEcCtD
Nitroglycerin—Erythema—Paclitaxel—kidney cancer	0.000656	0.00114	CcSEcCtD
Nitroglycerin—Body temperature increased—Sorafenib—kidney cancer	0.000655	0.00113	CcSEcCtD
Nitroglycerin—Abdominal pain—Sorafenib—kidney cancer	0.000655	0.00113	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000652	0.00113	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Vincristine—kidney cancer	0.000652	0.00113	CcSEcCtD
Nitroglycerin—Pruritus—Erlotinib—kidney cancer	0.000651	0.00113	CcSEcCtD
Nitroglycerin—Eczema—Doxorubicin—kidney cancer	0.000641	0.00111	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000639	0.00111	CcSEcCtD
Nitroglycerin—Infection—Gemcitabine—kidney cancer	0.000635	0.0011	CcSEcCtD
Nitroglycerin—Dizziness—Vinblastine—kidney cancer	0.000633	0.0011	CcSEcCtD
Nitroglycerin—Dizziness—Everolimus—kidney cancer	0.000631	0.00109	CcSEcCtD
Nitroglycerin—Body temperature increased—Sunitinib—kidney cancer	0.00063	0.00109	CcSEcCtD
Nitroglycerin—Abdominal pain—Sunitinib—kidney cancer	0.00063	0.00109	CcSEcCtD
Nitroglycerin—Hypotension—Vincristine—kidney cancer	0.00063	0.00109	CcSEcCtD
Nitroglycerin—Bradycardia—Capecitabine—kidney cancer	0.00063	0.00109	CcSEcCtD
Nitroglycerin—Nervous system disorder—Gemcitabine—kidney cancer	0.000627	0.00109	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—kidney cancer	0.000624	0.00108	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—PDHB—kidney cancer	0.000622	0.00238	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Dactinomycin—kidney cancer	0.000622	0.00108	CcSEcCtD
Nitroglycerin—Skin disorder—Gemcitabine—kidney cancer	0.000621	0.00108	CcSEcCtD
Nitroglycerin—ALDH2—Biological oxidations—POMC—kidney cancer	0.00062	0.00237	CbGpPWpGaD
Nitroglycerin—Rhinitis—Capecitabine—kidney cancer	0.00062	0.00107	CcSEcCtD
Nitroglycerin—Vision blurred—Paclitaxel—kidney cancer	0.000618	0.00107	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Gemcitabine—kidney cancer	0.000618	0.00107	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000617	0.00107	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—kidney cancer	0.000616	0.00107	CcSEcCtD
Nitroglycerin—Pharyngitis—Capecitabine—kidney cancer	0.000614	0.00106	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000611	0.00106	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—kidney cancer	0.000611	0.00106	CcSEcCtD
Nitroglycerin—Hypersensitivity—Sorafenib—kidney cancer	0.00061	0.00106	CcSEcCtD
Nitroglycerin—Oedema peripheral—Capecitabine—kidney cancer	0.000609	0.00105	CcSEcCtD
Nitroglycerin—Vomiting—Vinblastine—kidney cancer	0.000609	0.00105	CcSEcCtD
Nitroglycerin—Dizziness—Erlotinib—kidney cancer	0.000609	0.00105	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IGF2—kidney cancer	0.000608	0.00232	CbGpPWpGaD
Nitroglycerin—Vomiting—Everolimus—kidney cancer	0.000607	0.00105	CcSEcCtD
Nitroglycerin—Paraesthesia—Vincristine—kidney cancer	0.000605	0.00105	CcSEcCtD
Nitroglycerin—Agitation—Paclitaxel—kidney cancer	0.000603	0.00104	CcSEcCtD
Nitroglycerin—Rash—Everolimus—kidney cancer	0.000602	0.00104	CcSEcCtD
Nitroglycerin—Dermatitis—Everolimus—kidney cancer	0.000601	0.00104	CcSEcCtD
Nitroglycerin—Headache—Vinblastine—kidney cancer	0.0006	0.00104	CcSEcCtD
Nitroglycerin—Angioedema—Paclitaxel—kidney cancer	0.000599	0.00104	CcSEcCtD
Nitroglycerin—Headache—Everolimus—kidney cancer	0.000598	0.00103	CcSEcCtD
Nitroglycerin—Hypotension—Gemcitabine—kidney cancer	0.000597	0.00103	CcSEcCtD
Nitroglycerin—Body temperature increased—Dactinomycin—kidney cancer	0.000596	0.00103	CcSEcCtD
Nitroglycerin—Abdominal pain—Dactinomycin—kidney cancer	0.000596	0.00103	CcSEcCtD
Nitroglycerin—Visual impairment—Capecitabine—kidney cancer	0.000596	0.00103	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000595	0.00103	CcSEcCtD
Nitroglycerin—Asthenia—Sorafenib—kidney cancer	0.000594	0.00103	CcSEcCtD
Nitroglycerin—Vertigo—Paclitaxel—kidney cancer	0.000589	0.00102	CcSEcCtD
Nitroglycerin—Syncope—Paclitaxel—kidney cancer	0.000588	0.00102	CcSEcCtD
Nitroglycerin—Hypersensitivity—Sunitinib—kidney cancer	0.000587	0.00102	CcSEcCtD
Nitroglycerin—Pruritus—Sorafenib—kidney cancer	0.000586	0.00101	CcSEcCtD
Nitroglycerin—Vomiting—Erlotinib—kidney cancer	0.000585	0.00101	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CCBL1—kidney cancer	0.000585	0.00223	CbGpPWpGaD
Nitroglycerin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000582	0.00101	CcSEcCtD
Nitroglycerin—Rash—Erlotinib—kidney cancer	0.00058	0.001	CcSEcCtD
Nitroglycerin—Dermatitis—Erlotinib—kidney cancer	0.00058	0.001	CcSEcCtD
Nitroglycerin—Palpitations—Paclitaxel—kidney cancer	0.00058	0.001	CcSEcCtD
Nitroglycerin—Headache—Erlotinib—kidney cancer	0.000577	0.000998	CcSEcCtD
Nitroglycerin—Loss of consciousness—Paclitaxel—kidney cancer	0.000577	0.000998	CcSEcCtD
Nitroglycerin—Paraesthesia—Gemcitabine—kidney cancer	0.000574	0.000994	CcSEcCtD
Nitroglycerin—Flushing—Capecitabine—kidney cancer	0.000574	0.000993	CcSEcCtD
Nitroglycerin—Cardiac disorder—Capecitabine—kidney cancer	0.000574	0.000993	CcSEcCtD
Nitroglycerin—Asthenia—Sunitinib—kidney cancer	0.000572	0.00099	CcSEcCtD
Nitroglycerin—Dyspnoea—Gemcitabine—kidney cancer	0.00057	0.000987	CcSEcCtD
Nitroglycerin—Nausea—Vinblastine—kidney cancer	0.000569	0.000985	CcSEcCtD
Nitroglycerin—Somnolence—Gemcitabine—kidney cancer	0.000568	0.000984	CcSEcCtD
Nitroglycerin—Nausea—Everolimus—kidney cancer	0.000567	0.000981	CcSEcCtD
Nitroglycerin—Pruritus—Sunitinib—kidney cancer	0.000564	0.000976	CcSEcCtD
Nitroglycerin—Angiopathy—Capecitabine—kidney cancer	0.000561	0.000971	CcSEcCtD
Nitroglycerin—Immune system disorder—Capecitabine—kidney cancer	0.000559	0.000967	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Capecitabine—kidney cancer	0.000557	0.000965	CcSEcCtD
Nitroglycerin—Hypersensitivity—Dactinomycin—kidney cancer	0.000556	0.000962	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000555	0.00096	CcSEcCtD
Nitroglycerin—Arrhythmia—Capecitabine—kidney cancer	0.000552	0.000956	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000552	0.000956	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Vincristine—kidney cancer	0.000551	0.000954	CcSEcCtD
Nitroglycerin—Dizziness—Sorafenib—kidney cancer	0.000548	0.000948	CcSEcCtD
Nitroglycerin—Nausea—Erlotinib—kidney cancer	0.000547	0.000946	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000543	0.00207	CbGpPWpGaD
Nitroglycerin—Mental disorder—Capecitabine—kidney cancer	0.000542	0.000938	CcSEcCtD
Nitroglycerin—Asthenia—Dactinomycin—kidney cancer	0.000541	0.000937	CcSEcCtD
Nitroglycerin—Confusional state—Paclitaxel—kidney cancer	0.00054	0.000934	CcSEcCtD
Nitroglycerin—Erythema—Capecitabine—kidney cancer	0.000538	0.000932	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000535	0.000927	CcSEcCtD
Nitroglycerin—Abdominal pain—Vincristine—kidney cancer	0.000533	0.000922	CcSEcCtD
Nitroglycerin—Body temperature increased—Vincristine—kidney cancer	0.000533	0.000922	CcSEcCtD
Nitroglycerin—Infection—Paclitaxel—kidney cancer	0.000532	0.000921	CcSEcCtD
Nitroglycerin—Dizziness—Sunitinib—kidney cancer	0.000527	0.000912	CcSEcCtD
Nitroglycerin—Feeling abnormal—Gemcitabine—kidney cancer	0.000527	0.000912	CcSEcCtD
Nitroglycerin—Shock—Paclitaxel—kidney cancer	0.000527	0.000912	CcSEcCtD
Nitroglycerin—Vomiting—Sorafenib—kidney cancer	0.000527	0.000911	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000526	0.000911	CcSEcCtD
Nitroglycerin—Nervous system disorder—Paclitaxel—kidney cancer	0.000525	0.000909	CcSEcCtD
Nitroglycerin—Tachycardia—Paclitaxel—kidney cancer	0.000522	0.000904	CcSEcCtD
Nitroglycerin—Rash—Sorafenib—kidney cancer	0.000522	0.000904	CcSEcCtD
Nitroglycerin—Dermatitis—Sorafenib—kidney cancer	0.000522	0.000903	CcSEcCtD
Nitroglycerin—Skin disorder—Paclitaxel—kidney cancer	0.00052	0.0009	CcSEcCtD
Nitroglycerin—Headache—Sorafenib—kidney cancer	0.000519	0.000898	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000518	0.000896	CcSEcCtD
Nitroglycerin—Vision blurred—Capecitabine—kidney cancer	0.000507	0.000878	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—PPAT—kidney cancer	0.000507	0.00194	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GLIPR1—kidney cancer	0.000507	0.00194	CbGpPWpGaD
Nitroglycerin—Vomiting—Sunitinib—kidney cancer	0.000507	0.000877	CcSEcCtD
Nitroglycerin—Body temperature increased—Gemcitabine—kidney cancer	0.000505	0.000875	CcSEcCtD
Nitroglycerin—Rash—Sunitinib—kidney cancer	0.000502	0.00087	CcSEcCtD
Nitroglycerin—Dermatitis—Sunitinib—kidney cancer	0.000502	0.000869	CcSEcCtD
Nitroglycerin—Hypotension—Paclitaxel—kidney cancer	0.0005	0.000866	CcSEcCtD
Nitroglycerin—Headache—Sunitinib—kidney cancer	0.000499	0.000864	CcSEcCtD
Nitroglycerin—Hypersensitivity—Vincristine—kidney cancer	0.000497	0.00086	CcSEcCtD
Nitroglycerin—Nausea—Sorafenib—kidney cancer	0.000492	0.000851	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—kidney cancer	0.000485	0.00084	CcSEcCtD
Nitroglycerin—Vertigo—Capecitabine—kidney cancer	0.000484	0.000837	CcSEcCtD
Nitroglycerin—Asthenia—Vincristine—kidney cancer	0.000484	0.000837	CcSEcCtD
Nitroglycerin—Syncope—Capecitabine—kidney cancer	0.000483	0.000836	CcSEcCtD
Nitroglycerin—Paraesthesia—Paclitaxel—kidney cancer	0.000481	0.000832	CcSEcCtD
Nitroglycerin—Vomiting—Dactinomycin—kidney cancer	0.00048	0.00083	CcSEcCtD
Nitroglycerin—Dyspnoea—Paclitaxel—kidney cancer	0.000477	0.000826	CcSEcCtD
Nitroglycerin—Somnolence—Paclitaxel—kidney cancer	0.000476	0.000824	CcSEcCtD
Nitroglycerin—Palpitations—Capecitabine—kidney cancer	0.000476	0.000823	CcSEcCtD
Nitroglycerin—Rash—Dactinomycin—kidney cancer	0.000476	0.000823	CcSEcCtD
Nitroglycerin—Nausea—Sunitinib—kidney cancer	0.000473	0.000819	CcSEcCtD
Nitroglycerin—Loss of consciousness—Capecitabine—kidney cancer	0.000473	0.000819	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—FH—kidney cancer	0.000471	0.0018	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—APRT—kidney cancer	0.000471	0.0018	CbGpPWpGaD
Nitroglycerin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000462	0.0008	CcSEcCtD
Nitroglycerin—Asthenia—Gemcitabine—kidney cancer	0.000459	0.000794	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000455	0.000788	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000453	0.00173	CbGpPWpGaD
Nitroglycerin—Pruritus—Gemcitabine—kidney cancer	0.000452	0.000783	CcSEcCtD
Nitroglycerin—Nausea—Dactinomycin—kidney cancer	0.000448	0.000776	CcSEcCtD
Nitroglycerin—Dizziness—Vincristine—kidney cancer	0.000446	0.000771	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—kidney cancer	0.000444	0.000769	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—kidney cancer	0.000444	0.000769	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—kidney cancer	0.000444	0.000769	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GPC3—kidney cancer	0.000443	0.00169	CbGpPWpGaD
Nitroglycerin—Confusional state—Capecitabine—kidney cancer	0.000443	0.000767	CcSEcCtD
Nitroglycerin—Feeling abnormal—Paclitaxel—kidney cancer	0.000441	0.000764	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000438	0.000758	CcSEcCtD
Nitroglycerin—Infection—Capecitabine—kidney cancer	0.000436	0.000755	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—kidney cancer	0.000433	0.000749	CcSEcCtD
Nitroglycerin—Shock—Capecitabine—kidney cancer	0.000432	0.000748	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CA2—kidney cancer	0.000431	0.00165	CbGpPWpGaD
Nitroglycerin—Nervous system disorder—Capecitabine—kidney cancer	0.000431	0.000746	CcSEcCtD
Nitroglycerin—Tachycardia—Capecitabine—kidney cancer	0.000429	0.000742	CcSEcCtD
Nitroglycerin—Vomiting—Vincristine—kidney cancer	0.000429	0.000742	CcSEcCtD
Nitroglycerin—Skin disorder—Capecitabine—kidney cancer	0.000427	0.000739	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—kidney cancer	0.000426	0.000737	CcSEcCtD
Nitroglycerin—Urticaria—Paclitaxel—kidney cancer	0.000425	0.000736	CcSEcCtD
Nitroglycerin—Rash—Vincristine—kidney cancer	0.000425	0.000736	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Capecitabine—kidney cancer	0.000425	0.000735	CcSEcCtD
Nitroglycerin—Dermatitis—Vincristine—kidney cancer	0.000425	0.000735	CcSEcCtD
Nitroglycerin—Abdominal pain—Paclitaxel—kidney cancer	0.000423	0.000733	CcSEcCtD
Nitroglycerin—Body temperature increased—Paclitaxel—kidney cancer	0.000423	0.000733	CcSEcCtD
Nitroglycerin—Headache—Vincristine—kidney cancer	0.000422	0.000731	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ALAD—kidney cancer	0.00042	0.0016	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—BRAF—kidney cancer	0.000416	0.00159	CbGpPWpGaD
Nitroglycerin—Hypotension—Capecitabine—kidney cancer	0.000411	0.000711	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ST3GAL2—kidney cancer	0.00041	0.00157	CbGpPWpGaD
Nitroglycerin—Vomiting—Gemcitabine—kidney cancer	0.000407	0.000704	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—kidney cancer	0.000406	0.000702	CcSEcCtD
Nitroglycerin—Rash—Gemcitabine—kidney cancer	0.000403	0.000698	CcSEcCtD
Nitroglycerin—Dermatitis—Gemcitabine—kidney cancer	0.000403	0.000697	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ALDH1A1—kidney cancer	0.000401	0.00153	CbGpPWpGaD
Nitroglycerin—Headache—Gemcitabine—kidney cancer	0.000401	0.000693	CcSEcCtD
Nitroglycerin—Nausea—Vincristine—kidney cancer	0.0004	0.000693	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—kidney cancer	0.0004	0.000692	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—kidney cancer	0.000396	0.000685	CcSEcCtD
Nitroglycerin—Paraesthesia—Capecitabine—kidney cancer	0.000394	0.000683	CcSEcCtD
Nitroglycerin—Hypersensitivity—Paclitaxel—kidney cancer	0.000394	0.000683	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—kidney cancer	0.000393	0.00068	CcSEcCtD
Nitroglycerin—Dyspnoea—Capecitabine—kidney cancer	0.000392	0.000678	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SLC5A3—kidney cancer	0.000384	0.00147	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PGK1—kidney cancer	0.000384	0.00147	CbGpPWpGaD
Nitroglycerin—Visual impairment—Doxorubicin—kidney cancer	0.000384	0.000665	CcSEcCtD
Nitroglycerin—Asthenia—Paclitaxel—kidney cancer	0.000384	0.000665	CcSEcCtD
Nitroglycerin—Nausea—Gemcitabine—kidney cancer	0.00038	0.000657	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000379	0.000657	CcSEcCtD
Nitroglycerin—Pruritus—Paclitaxel—kidney cancer	0.000379	0.000656	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—LDHB—kidney cancer	0.000377	0.00144	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—RAF1—kidney cancer	0.000375	0.00143	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—RAF1—kidney cancer	0.000375	0.00143	CbGpPWpGaD
Nitroglycerin—Cardiac disorder—Doxorubicin—kidney cancer	0.00037	0.00064	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—kidney cancer	0.00037	0.00064	CcSEcCtD
Nitroglycerin—Feeling abnormal—Capecitabine—kidney cancer	0.000362	0.000627	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—kidney cancer	0.000362	0.000626	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—kidney cancer	0.00036	0.000623	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000359	0.000622	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—kidney cancer	0.000359	0.000622	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—kidney cancer	0.000356	0.000616	CcSEcCtD
Nitroglycerin—Dizziness—Paclitaxel—kidney cancer	0.000354	0.000613	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—kidney cancer	0.000349	0.000604	CcSEcCtD
Nitroglycerin—Urticaria—Capecitabine—kidney cancer	0.000349	0.000604	CcSEcCtD
Nitroglycerin—Body temperature increased—Capecitabine—kidney cancer	0.000347	0.000601	CcSEcCtD
Nitroglycerin—Abdominal pain—Capecitabine—kidney cancer	0.000347	0.000601	CcSEcCtD
Nitroglycerin—ALDH2—Neuronal System—RAF1—kidney cancer	0.000347	0.00133	CbGpPWpGaD
Nitroglycerin—Erythema—Doxorubicin—kidney cancer	0.000347	0.000601	CcSEcCtD
Nitroglycerin—Vomiting—Paclitaxel—kidney cancer	0.00034	0.000589	CcSEcCtD
Nitroglycerin—Rash—Paclitaxel—kidney cancer	0.000338	0.000584	CcSEcCtD
Nitroglycerin—Dermatitis—Paclitaxel—kidney cancer	0.000337	0.000584	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—IL2—kidney cancer	0.000337	0.00129	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—IL2—kidney cancer	0.000337	0.00129	CbGpPWpGaD
Nitroglycerin—Headache—Paclitaxel—kidney cancer	0.000335	0.000581	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—RAF1—kidney cancer	0.000335	0.00128	CbGpPWpGaD
Nitroglycerin—Vision blurred—Doxorubicin—kidney cancer	0.000327	0.000566	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CA9—kidney cancer	0.000327	0.00125	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Capecitabine—kidney cancer	0.000324	0.00056	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—kidney cancer	0.000319	0.000552	CcSEcCtD
Nitroglycerin—Nausea—Paclitaxel—kidney cancer	0.000318	0.00055	CcSEcCtD
Nitroglycerin—Asthenia—Capecitabine—kidney cancer	0.000315	0.000546	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—kidney cancer	0.000312	0.00054	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—kidney cancer	0.000311	0.000539	CcSEcCtD
Nitroglycerin—Pruritus—Capecitabine—kidney cancer	0.000311	0.000538	CcSEcCtD
Nitroglycerin—ALDH2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000311	0.00119	CbGpPWpGaD
Nitroglycerin—Palpitations—Doxorubicin—kidney cancer	0.000307	0.000531	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—kidney cancer	0.000305	0.000528	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—IL2—kidney cancer	0.0003	0.00115	CbGpPWpGaD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000293	0.000508	CcSEcCtD
Nitroglycerin—Dizziness—Capecitabine—kidney cancer	0.000291	0.000503	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—VEGFA—kidney cancer	0.000286	0.00109	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—VEGFA—kidney cancer	0.000286	0.00109	CbGpPWpGaD
Nitroglycerin—Confusional state—Doxorubicin—kidney cancer	0.000286	0.000494	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000283	0.00049	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—kidney cancer	0.000281	0.000487	CcSEcCtD
Nitroglycerin—Vomiting—Capecitabine—kidney cancer	0.000279	0.000483	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—kidney cancer	0.000279	0.000482	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—CRABP1—kidney cancer	0.000278	0.00106	CbGpPWpGaD
Nitroglycerin—Nervous system disorder—Doxorubicin—kidney cancer	0.000278	0.000481	CcSEcCtD
Nitroglycerin—Rash—Capecitabine—kidney cancer	0.000277	0.000479	CcSEcCtD
Nitroglycerin—Dermatitis—Capecitabine—kidney cancer	0.000277	0.000479	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—kidney cancer	0.000276	0.000478	CcSEcCtD
Nitroglycerin—Headache—Capecitabine—kidney cancer	0.000275	0.000476	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—kidney cancer	0.000275	0.000476	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—kidney cancer	0.000274	0.000474	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—MAPK3—kidney cancer	0.000271	0.00103	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—MAPK3—kidney cancer	0.000271	0.00103	CbGpPWpGaD
Nitroglycerin—Hypotension—Doxorubicin—kidney cancer	0.000265	0.000458	CcSEcCtD
Nitroglycerin—Nausea—Capecitabine—kidney cancer	0.000261	0.000452	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—ITPR2—kidney cancer	0.000258	0.000986	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—MAPK1—kidney cancer	0.000258	0.000984	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—MAPK1—kidney cancer	0.000258	0.000984	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—VEGFA—kidney cancer	0.000255	0.000974	CbGpPWpGaD
Nitroglycerin—Paraesthesia—Doxorubicin—kidney cancer	0.000254	0.00044	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—kidney cancer	0.000252	0.000437	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—kidney cancer	0.000252	0.000436	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000244	0.000423	CcSEcCtD
Nitroglycerin—GUCY1B3—Hemostasis—KRAS—kidney cancer	0.000243	0.000929	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—KRAS—kidney cancer	0.000243	0.000929	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—MAPK3—kidney cancer	0.000241	0.000921	CbGpPWpGaD
Nitroglycerin—ALDH2—Neuronal System—MAPK1—kidney cancer	0.000238	0.000909	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ACHE—kidney cancer	0.000236	0.0009	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTT1—kidney cancer	0.000236	0.0009	CbGpPWpGaD
Nitroglycerin—Feeling abnormal—Doxorubicin—kidney cancer	0.000233	0.000404	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000232	0.000401	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—MAPK1—kidney cancer	0.00023	0.000877	CbGpPWpGaD
Nitroglycerin—Urticaria—Doxorubicin—kidney cancer	0.000225	0.000389	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—kidney cancer	0.000224	0.000387	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—kidney cancer	0.000224	0.000387	CcSEcCtD
Nitroglycerin—GUCY1A2—Hemostasis—PIK3CA—kidney cancer	0.000223	0.000853	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—PIK3CA—kidney cancer	0.000223	0.000853	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SCARB1—kidney cancer	0.000223	0.000852	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS1—kidney cancer	0.000221	0.000843	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—KRAS—kidney cancer	0.000217	0.000828	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PSMD7—kidney cancer	0.000216	0.000827	CbGpPWpGaD
Nitroglycerin—GUCY1B3—Hemostasis—TP53—kidney cancer	0.000216	0.000826	CbGpPWpGaD
Nitroglycerin—GUCY1A2—Hemostasis—TP53—kidney cancer	0.000216	0.000826	CbGpPWpGaD
Nitroglycerin—Hypersensitivity—Doxorubicin—kidney cancer	0.000209	0.000361	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—BCHE—kidney cancer	0.000205	0.000784	CbGpPWpGaD
Nitroglycerin—Asthenia—Doxorubicin—kidney cancer	0.000203	0.000352	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—SLC5A5—kidney cancer	0.000203	0.000774	CbGpPWpGaD
Nitroglycerin—Pruritus—Doxorubicin—kidney cancer	0.0002	0.000347	CcSEcCtD
Nitroglycerin—GUCY1A3—Hemostasis—PIK3CA—kidney cancer	0.000199	0.000761	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—SLC2A1—kidney cancer	0.000196	0.000748	CbGpPWpGaD
Nitroglycerin—GUCY1A3—Hemostasis—TP53—kidney cancer	0.000193	0.000736	CbGpPWpGaD
Nitroglycerin—Dizziness—Doxorubicin—kidney cancer	0.000187	0.000324	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—kidney cancer	0.00018	0.000312	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—kidney cancer	0.000179	0.000309	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—kidney cancer	0.000178	0.000309	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—kidney cancer	0.000177	0.000307	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—kidney cancer	0.000168	0.000291	CcSEcCtD
Nitroglycerin—ALDH2—Metabolism—GSTP1—kidney cancer	0.000163	0.000624	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—ABCB1—kidney cancer	0.000155	0.00059	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—GSTM1—kidney cancer	0.00015	0.000573	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—CYP1A1—kidney cancer	0.000142	0.000543	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—POMC—kidney cancer	0.000106	0.000405	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTGS2—kidney cancer	8.46e-05	0.000323	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PTEN—kidney cancer	7.38e-05	0.000282	CbGpPWpGaD
Nitroglycerin—ALDH2—Metabolism—PIK3CA—kidney cancer	5.2e-05	0.000199	CbGpPWpGaD
